W. Black's Profile

Role	Title	Level	Year	L/R
🐬	The Role of Numeracy in Understanding the Benefit of Screening Mammography Lisa M. Schwartz, S. Woloshin, W. Black, H. Welch	10	1997	10 🐬
🐜	Addressing overdiagnosis and overtreatment in cancer: a prescription for change. 13 auth. L. Esserman, I. Thompson, B. Reid, P. Nelson, D. Ransohoff, H. Welch, Shelley E. Hwang, D. Berry, K. Kinzler, W. Black, ... M. Bissell, H. Parnes, S. Srivastava	8	2014	8 🐜
🦁	Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. W. Black, R. Nease, A. Tosteson	8	1995	8 🦁
🐢	Using Autopsy Series To Estimate the Disease Reservoir for Ductal Carcinoma in Situ of the Breast: How Much More Breast Cancer Can We Find? H. Welch, W. Black	7	1997	7 🐢
🐢	Epidemiologic Signatures in Cancer. H. Welch, Barnett S. Kramer, W. Black	6	2019	6 🐢
🦁	Screening for disease. W. Black, H. Welch	6	1997	6 🦁
🐬	Women's Perceptions of Breast Cancer Risk S. Woloshin, Lisa M. Schwartz, W. Black, H. Welch	6	1999	6 🐬
🐜	Comparing Benefits from Many Possible Computed Tomography Lung Cancer Screening Programs: Extrapolating from the National Lung Screening Trial Using Comparative Modeling 20 auth. P. McMahon, R. Meza, S. Plevritis, W. Black, C. Tammemagi, A. Erdogan, K. ten Haaf, W. Hazelton, T. Holford, Jihyoun Jeon, ... L. Clarke, C. Kong, Sung-Eun Choi, Vidit N. Munshi, Summer S. Han, J. van Rosmalen, P. Pinsky, S. Moolgavkar, H. D. de Koning, E. Feuer	5	2014	5 🐜
🐬	Determinants of melanoma in a case–control study of twins (United States) M. Cockburn, W. Black, W. McKelvey, T. Mack	3	2001	3 🐬
🐬	Increasing Trends in Mortality Rate Among Salivary Gland Tumors in Non-Geriatric African Americans Varsha Chiruvella, W. Black, A. Guddati	1	2022	1 🐬
🐬	Cost-effectiveness analysis of pembrolizumab versus standard of care in recurrent or metastatic squamous cell carcinoma of the head and neck Justin Yeh, W. Black, A. Guddati	0	2022	0 🐬